Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vuk Zdinjak

Evogene Q1 Revenue Decreases 28.82% YoY, What About Debt?

Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN) released its financial results for the first quarter ended March 31, 2022, revealing revenue of $237,000 in comparison to $333,000 in the same period the previous year.

Q1 Financial Highlights

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.